Bristol Myers Squibb (BMY) Ascends While Market Falls: Some Facts to NoteZacks Investment Research • 06/23/26
Bristol Myers Squibb to Report Results for Second Quarter 2026 on July 30, 2026Business Wire • 06/18/26
Elicio Therapeutics Points To Durable Responses As It Maps Next Steps For Lead Cancer DrugBenzinga • 06/17/26
A Dramatic Shift in Fed Policy Just Unlocked a New Era for Bristol Myers Squibb24/7 Wall Street • 06/15/26
Bristol Myers Squibb Dividend Raise Streak is 18 Years. Here's 1 Number That Says the Streak Will Continue.The Motley Fool • 06/11/26
Bristol Myers Squibb (BMY) is a Top-Ranked Value Stock: Should You Buy?Zacks Investment Research • 06/11/26
Takeda's AI-crafted psoriasis pill tops Bristol Myers' Sotyktu in head-to-head trialReuters • 06/11/26
Bristol-Myers Squibb Company (BMY) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptSeeking Alpha • 06/10/26
The space race is coming for pharma: Why drug development is heading to lower Earth orbitCNBC • 06/09/26
Mariska Hargitay Partners with Bristol Myers Squibb for “Investigating Myeloma” Awareness Campaign to Honor Her Father 20 Years After Losing Him to the DiseaseBusiness Wire • 06/08/26
Bristol Myers Squibb (BMY) Gains As Market Dips: What You Should KnowZacks Investment Research • 06/05/26
Billionaire Izzy Englander Just Made a Big Bet on This Beaten-Down High-Yield Dividend StockThe Motley Fool • 06/05/26
Arcus Biosciences Announces Clinical Trial Collaboration and Supply Agreement to Evaluate Casdatifan in Combination with PD‑L1/VEGF‑A Bispecific Immunomodulator to Treat Kidney CancerBusiness Wire • 06/03/26